Boehringer Ingelheim Animal Health Belgium SA
0445.411.231 · rovalta.com · 27/09/2026
Boehringer Ingelheim Animal Health Belgium SA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBoehringer Ingelheim Animal Health Belgium SA is a Public limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Ixelles. It employs on average 38,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0445.411.231
- Incorporation
- 08/10/1991
- Legal form
- Public limited company
- Registered office
- Avenue Arnaud Fraiteur 15/23
1050 Ixelles · BruxellesSee on map - Contributed capital
- 3 490 182,99 €
- Latest accounts
- 31/12/2025
- Average workforce
- 38,4 ETP
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 21 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 50,6 M € | +8.0% | 46,9 M € | +14.2% | 41 M € | +13.4% | 36,2 M € | +2.8% | 35,2 M € |
| EBITDA | 1,8 M € | -31.1% | 2,6 M € | +36.4% | 1,9 M € | -5.8% | 2,1 M € | +135% | 873,8 k € |
| Operating result | 723,2 k € | -66.5% | 2,2 M € | +58.4% | 1,4 M € | -19.1% | 1,7 M € | +90.7% | 884,3 k € |
| Net result | 234 k € | -83.0% | 1,4 M € | +74.2% | 787,9 k € | -21.5% | 1 M € | +146% | 408,5 k € |
| Balance sheet | |||||||||
| Equity | 4,2 M € | 0.0% | 4,2 M € | 0.0% | 4,2 M € | 0.0% | 4,2 M € | -19.1% | 5,2 M € |
| Total assets | 24 M € | +10.0% | 21,9 M € | +20.6% | 18,1 M € | +4.8% | 17,3 M € | -1.7% | 17,6 M € |
| Cash | – | – | – | – | – | ||||
| Debts | 18,8 M € | +13.0% | 16,6 M € | +29.3% | 12,9 M € | +5.2% | 12,2 M € | +6.4% | 11,5 M € |
| Other | |||||||||
| Workforce | 38,4 ETP | -0.8% | 38,7 ETP | +1.6% | 38,1 ETP | +4.1% | 36,6 ETP | +8.3% | 33,8 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20259 active · 33 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Stephan KRICK | Managing director | 01/06/2026 → 31/05/2029 | |
Lukas HAUSCHILD | Director | 01/05/2026 → 30/04/2029 | 000 |
Carla RAMON | Director | 09/03/2026 → 08/03/2029 | 000 |
Christoph TAUTPHAEUS | Director | 01/11/2025 → 01/05/2026 | |
Larisa NURKANOVIC | Director | 01/11/2025 → 09/03/2026 | |
Carla RAMON | Director | 01/04/2025 → 01/11/2025 | 000 |
Sebastian GUIJARRO | Director | 06/04/2024 → 30/11/2025 | 000 |
Chiedza KAITANO | Director | 15/03/2024 → 03/03/2025 | |
Luis Miguel VITORIA MAGRO CORREIA | Managing director | 15/06/2023 → 01/10/2025 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sebastian GUIJARRO | Director | 06/04/2024 → 11/06/2031 | 000 |
Chiedza KAITANO | Director | 15/03/2024 → 11/06/2031 | |
Eva PORTA SOLDEVILA | Director | 09/10/2023 → 06/04/2024 | |
Luis Miguel VITORIA MAGRO CORREIA | Managing director | 15/06/2023 → 14/06/2028 |
Other companies at this address
Avenue Arnaud Fraiteur 15/23 1050 Ixelles| Company | CBE no. |
|---|---|
A.J.B. INTERIEUR● Active | 0457.572.754 |
ALIAXIS● Active | 0860.005.067 |
ANK4PAT● Active | 0704.672.138 |
ARTSNBE● Active | 0678.993.169 |
BeeOdiversity● Active | 0848.557.582 |
BOEHRINGER INGELHEIM CENTRE SA● Active | 0448.020.729 |
Boehringer Ingelheim SComm● Active | 0435.953.632 |
CODINSANITY● Active | 0699.660.802 |
DATA WIZARDS SOLUTIONS● Active | 0792.385.179 |
DYNA Specialist● Active | 0779.400.047 |
ENTITY FACTORY● Active | 1003.909.418 |
ERATHIS● Active | 0783.780.388 |
EVOLUNO● Active | 0758.358.272 |
FESTRA● Active | 0648.886.646 |
GLUCÔNE● Active | 0878.220.776 |
GUZMANZI● Active | 0782.965.885 |
Health INN-PACT● Active | 0726.794.571 |
JH PARTNERS● Active | 1022.465.023 |
Krys Construct● Active | 0534.791.781 |
Laboratoires Titra● Bankrupt | 0402.249.102 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 26/06/2025 | 26/06/2024 | 20/06/2023 | 22/06/2022 | 21/06/2021 |
| General meeting | 26/06/2026 | 25/06/2025 | 12/06/2024 | 14/06/2023 | 08/06/2022 | 09/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 26/06/2026 | 29/06/2026 | French | |
| Full model | 31/12/2024 | 25/06/2025 | 26/06/2025 | French | |
| Full model | 31/12/2023 | 12/06/2024 | 26/06/2024 | French | |
| Full model | 31/12/2022 | 14/06/2023 | 20/06/2023 | French | |
| Full model | 31/12/2021 | 08/06/2022 | 22/06/2022 | French | |
| Full model | 31/12/2020 | 09/06/2021 | 21/06/2021 | French | |
| Full model | 31/12/2019 | 10/06/2020 | 16/06/2020 | French | |
| Full model | 31/12/2018 | 12/06/2019 | 27/06/2019 | French | |
| Full model | 31/12/2017 | 13/06/2018 | 26/06/2018 | French | |
| Full model | 31/12/2016 | 14/06/2017 | 29/06/2017 | Dutch | |
| Full model | 31/12/2015 | 08/06/2016 | 08/07/2016 | Dutch | |
| Full model | 31/12/2014 | 10/06/2015 | 24/06/2015 | Dutch | |
| Full model | 31/12/2013 | 11/06/2014 | 01/07/2014 | Dutch | |
| Full model | 31/12/2012 | 12/06/2013 | 28/06/2013 | Dutch | |
| Full model | 31/12/2011 | 13/06/2012 | 03/08/2012 | Dutch | |
| Full model | 31/12/2010 | 08/06/2011 | 27/06/2011 | French | |
| Full model | 31/12/2009 | 09/06/2010 | 28/06/2010 | French | |
| Full model | 31/12/2008 | 10/06/2009 | 29/06/2009 | French | |
| Full model | 31/12/2007 | 11/06/2008 | 04/07/2008 | French | |
| Full modelCorrection | 31/12/2006 | 13/06/2007 | 12/09/2007 | French | |
| Full model | 31/12/2006 | 13/06/2007 | 09/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20259 active · 33 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Stephan KRICK | Managing director | 01/06/2026 → 31/05/2029 | |
Lukas HAUSCHILD | Director | 01/05/2026 → 30/04/2029 | 000 |
Carla RAMON | Director | 09/03/2026 → 08/03/2029 | 000 |
Christoph TAUTPHAEUS | Director | 01/11/2025 → 01/05/2026 | |
Larisa NURKANOVIC | Director | 01/11/2025 → 09/03/2026 | |
Carla RAMON | Director | 01/04/2025 → 01/11/2025 | 000 |
Sebastian GUIJARRO | Director | 06/04/2024 → 30/11/2025 | 000 |
Chiedza KAITANO | Director | 15/03/2024 → 03/03/2025 | |
Luis Miguel VITORIA MAGRO CORREIA | Managing director | 15/06/2023 → 01/10/2025 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sebastian GUIJARRO | Director | 06/04/2024 → 11/06/2031 | 000 |
Chiedza KAITANO | Director | 15/03/2024 → 11/06/2031 | |
Eva PORTA SOLDEVILA | Director | 09/10/2023 → 06/04/2024 | |
Luis Miguel VITORIA MAGRO CORREIA | Managing director | 15/06/2023 → 14/06/2028 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates22/05/2026DEMISSIONS, NOMINATIONS
- Other16/04/2026STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates23/02/2026DEMISSIONS, NOMINATIONS
- Mandates27/05/2025DEMISSIONS, NOMINATIONS
- Mandates09/10/2024DEMISSIONS, NOMINATIONS
- Mandates13/08/2024ONTSLAGEN - BENOEMINGEN
- Mandates22/05/2024DEMISSIONS, NOMINATIONS
- Mandates10/11/2023DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025234 k €↓
- 2024Annual accounts 20241,4 M €↑
- 2023Annual accounts 2023787,9 k €↓
- 2022Annual accounts 20221 M €↑
- 2021Annual accounts 2021408,5 k €↓
- 2020Annual accounts 2020965,4 k €↑
- 2019Annual accounts 2019639,9 k €↑
- 2018Annual accounts 201890,7 k €↑
- 2017Annual accounts 2017-207,4 k €↓
- 2017Name changeBoehringer Ingelheim Animal Health Belgium SA
- 2016Annual accounts 2016477,4 k €↓
- 2015Annual accounts 2015572,6 k €↑
- 2014Annual accounts 2014563,8 k €↓
- 2013Annual accounts 2013686,5 k €↑
- 2012Annual accounts 2012354,1 k €↓
- 2011Annual accounts 2011450 k €↓
- 2010Annual accounts 2010666,4 k €↓
- 2009Annual accounts 20091,3 M €↑
- 2008Annual accounts 20081,2 M €↑
- 2007Annual accounts 20071,1 M €↑
- 2006Annual accounts 2006806,9 k €
- 08/10/1991IncorporationPublic limited company
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Boehringer Ingelheim Animal Health Belgium SACurrent | accounts 2017 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00238250 |
| MERIAL BELGIUM | accounts 2006 → 2016 | Accounts 2016 · 2017-24700490 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.